{
  "id": 13938645,
  "title": "Boehringer Ingelheim premieres short film to raise awareness of pulmonary fibrosis in the UAE",
  "url": "https://urgent.news/2026/10/12/boehringer-ingelheim-premieres-short-film-to-raise-awareness-of",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-12T11:04:05.000Z",
  "source": {
    "name": "The National UAE",
    "slug": "the-national-uae",
    "url": "https://www.thenationalnews.com/advertorial/2026/10/12/boehringer-ingelheim-premieres-short-film-to-raise-awareness-of-pulmonary-fibrosis-in-the-uae/"
  },
  "original_language": "en",
  "account": "Boehringer Ingelheim, a prominent research-focused pharmaceutical company, introduced a brief film to enhance understanding of pulmonary fibrosis in the United Arab Emirates (UAE). This initiative is part of a broader campaign to increase awareness of idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF), two severe lung disorders that significantly affect patients' daily lives. The film screening took place in Dubai, gathering leading pulmonology and rheumatology experts, such as Dr. Bassam Mahboub, vice president of the Emirates Thoracic Society, and Dr. Shamma Al Nokhatha, president of the Emirates Society for Rheumatology.\n\nPulmonary fibrosis and progressive pulmonary fibrosis are marked by lung tissue scarring, leading to irreversible lung function decline and difficulty in oxygen intake. IPF has no known cause, while PPF can develop in individuals with other conditions, such as rheumatoid arthritis. Typical symptoms, including persistent dry cough, shortness of breath, and fatigue, are often dismissed as signs of aging or lack of fitness.\n\nDr. Ousama Alhaj, the general manager and head of human pharma at Boehringer Ingelheim in the Near East and UAE, emphasized the company's long history in respiratory health and its belief that scientific advancements must align with heightened disease awareness and timely diagnosis. Recent advancements in pulmonary fibrosis treatment within the UAE mark significant progress for both patients and healthcare professionals striving to improve disease management.\n\nAlthough IPF and PPF are considered rare, together they affect up to 9.2 million people globally. Early recognition is crucial due to their progressive nature, yet studies indicate that diagnosis can be delayed by one to two years. Dr. Mahboub noted that pulmonary fibrosis care is transitioning towards earlier detection, multidisciplinary assessment, and prompt action within the patient journey. The challenge now is to ensure that a seemingly dismissible symptom like breathlessness prompts further investigation rather than being overlooked.\n\nThe awareness campaign coincides with the recent approval of a new treatment option for IPF and PPF, a milestone following a decade without a new treatment demonstrating efficacy in IPF. This progress is vital for those living with these progressive diseases. The subsequent chapter in pulmonary fibrosis care should focus not only on scientific advancements but also on effectively translating that progress into earlier recognition and enhanced patient experiences. This requires strengthening awareness among patients, families, and healthcare professionals, ensuring those with persistent symptoms are connected to appropriate care at the right time. Innovation has the greatest impact for patients in this regard.",
  "summary": "Boehringer Ingelheim, a leading research-driven biopharmaceutical company, has premiered a new short film as part of a campaign to raise awareness of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis, two progressive lung conditions that can have a profound impact on patients’ everyday lives. Hosted in Dubai, the premiere brought together leading pulmonology and rheumatology…",
  "key_points": [
    "Boehringer Ingelheim releases short film to raise awareness of pulmonary fibrosis in UAE.",
    "Film screening in Dubai includes leading pulmonology and rheumatology experts.",
    "IPF and PPF affect up to 9.2 million people globally, with delayed diagnosis."
  ],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "The National Business",
        "title": "Boehringer Ingelheim premieres short film to raise awareness of pulmonary fibrosis in the UAE",
        "url": "https://urgent.news/2026/10/12/boehringer-ingelheim-premieres-short-film-to-raise-awareness-of-13943586",
        "published": "2026-10-12T11:04:05.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}